Osteonorm (Clodronate Disodium, Lidocaine Hydrochloride)

Clodronate Disodium, the active ingredient in Osteonorm, is a bisphosphonate presented as an injectable formulation for intramuscular use. It is employed in the management of bone‑related conditions, particularly those involving excessive bone turnover. GNH USA supplies Osteonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

GNH USA supplies Osteonorm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and clinics worldwide.

Osteonorm, a bisphosphonate, is used in disorders that affect bone metabolism: - Osteoporosis: helps reduce the incidence of vertebral fractures by inhibiting bone resorption. - Paget’s disease of bone: decreases abnormal bone remodeling and associated pain. - Hypercalcaemia of malignancy: assists in lowering serum calcium levels. - Bone metastasis‑related pain: provides analgesic benefit through reduced osteoclast activity.

Adverse reactions to Osteonram may include:

Common Side Effects: - Pain at the injection site  - Mild nausea - Transient fever  - Headache - Flushing  - Dizziness

Serious or Rare Side Effects: - Severe hypersensitivity or anaphylaxis  - Acute renal injury  - Atypical femoral fractures  - Osteonecrosis of the jaw (ONJ) - Electrolyte disturbances such as hypocalcaemia  - Unexplained cardiac arrhythmias

When using Oste ​  ​     ...

Potential ...